Search
for
Sort by
Research 331–360 of 1000+
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo
- Cellular Plasticity in Cutaneous Wound Healing
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- 1319 Claudin-1 and -3 maintain proper hair follicle structure and regulate telogen effluvium
- 1320 Orchestrated cytotoxic and skin migratory ability lacking self-tolerance: circulating γδT-cells may promote alopecia areata
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- Alopecia
- 265 Loss of Langerhans cells in scar lesion of lichen planopilaris is caused by downregulation of integrin αvβ6 in the epidermal keratinocytes
- Medications
- Cutaneous Lupus Erythematosus
- Highlights from the 68th Annual Meeting of the Society of Investigative Dermatology
- Primary cicatricial alopecia: Recent advances in understanding and management
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- AB0442 Real-life experience with belimumab in systemic lupus erythematosus (SLE): control of disease activity and flares in a multicenter cohort
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Estrogen induce VEGF expression in dermal papilla cells
- Renbök phenomenon: Alopecia areata sparing psoriasis plaques
- Recalcitrant widespread alopecia areata in a child treated successfully with oral methylprednisolone pulse therapy
- Vitamin D and the skin: Focus on a complex relationship: A review
- Neurogenic Inflammation in Stress-Induced Termination of Murine Hair Growth Is Promoted by Nerve Growth Factor
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Emerging treatments in alopecia
- Alopecia Areata
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review)
- ADVANCES IN PSORIASIS THERAPY
- Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia
- Skin eruptions specific to pregnancy: an overview
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report